Can 80 mg of daily steroids cause hyperglycemia (Blood Glucose >500 mg/dL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid-Induced Hyperglycemia and Blood Glucose Levels Above 500 mg/dL

Yes, 80 mg of daily steroids can absolutely cause blood glucose levels to exceed 500 mg/dL, particularly in patients with pre-existing diabetes or risk factors for diabetes. 1, 2

Mechanism and Prevalence

  • Glucocorticoids induce hyperglycemia through multiple mechanisms: impaired beta cell insulin secretion, increased insulin resistance, and enhanced hepatic gluconeogenesis 1
  • Steroid-induced hyperglycemia occurs in 56-86% of hospitalized patients with and without pre-existing diabetes 1
  • The degree of hyperglycemia directly correlates with the steroid dose - higher doses (such as 80 mg) cause more significant elevations in blood glucose 1, 2
  • In patients receiving high-dose steroids, 70% of subjects had at least one blood glucose reading ≥10 mmol/L (180 mg/dL), and many had significantly higher readings 3

Pattern of Hyperglycemia

  • The hyperglycemic effect is most pronounced during the day (particularly afternoon and evening) and often normalizes overnight 1
  • Peak hyperglycemic effects typically occur 6-9 hours after administration of morning steroids 1, 4
  • The highest glucose concentrations are typically detected on the 3rd day of steroid therapy 4
  • For once-daily morning steroid regimens, glucose levels peak in the afternoon and often return to baseline by the next morning 3

Severity of Hyperglycemia

  • For higher doses of glucocorticoids (like 80 mg), increasing doses of prandial and correctional insulin, sometimes in extraordinary amounts, are often needed in addition to basal insulin 5
  • Patients with pre-existing diabetes are at particularly high risk, with mean maximal changes in serum glucose being significantly greater than in those without diabetes 6
  • Severe hyperglycemia (including levels >500 mg/dL) can occur, especially in patients with:
    • Pre-existing diabetes 1
    • Higher steroid doses (80 mg is considered a high dose) 2
    • Longer duration of steroid therapy 7
    • Multiple daily steroid doses 5

Management Considerations

  • Blood glucose monitoring should be performed four times daily (fasting and 2 hours after each meal) when on high-dose steroids 1
  • For significant hyperglycemia with high-dose steroids, NPH insulin at 0.3-0.5 units/kg/day is recommended, with higher doses needed for higher steroid doses 1, 2
  • For long-acting glucocorticoids or continuous use, long-acting insulin may be required to control fasting blood glucose 5, 1
  • Monitor for hyperosmolar hyperglycemic state, a life-threatening complication of severe steroid-induced hyperglycemia that can present with extremely high glucose levels 1

Risk Stratification

  • Patients with pre-existing diabetes are at highest risk for severe hyperglycemia 8
  • Even patients with prediabetes have double the incidence of steroid-induced hyperglycemia compared to those with normal glucose tolerance 8
  • Patients without known glucose abnormalities can still develop significant hyperglycemia on high-dose steroids 3

In conclusion, 80 mg of daily steroids represents a high dose that can certainly cause blood glucose levels to exceed 500 mg/dL, particularly in patients with underlying diabetes or risk factors for diabetes. This severe hyperglycemia requires aggressive monitoring and treatment to prevent complications.

References

Guideline

Management of Steroid-Induced Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The high incidence of steroid-induced hyperglycaemia in hospital.

Diabetes research and clinical practice, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.